KR101738937B1 - 개과 동물의 호흡기 질병 조절을 위한 물질 및 방법들 - Google Patents

개과 동물의 호흡기 질병 조절을 위한 물질 및 방법들 Download PDF

Info

Publication number
KR101738937B1
KR101738937B1 KR1020147017285A KR20147017285A KR101738937B1 KR 101738937 B1 KR101738937 B1 KR 101738937B1 KR 1020147017285 A KR1020147017285 A KR 1020147017285A KR 20147017285 A KR20147017285 A KR 20147017285A KR 101738937 B1 KR101738937 B1 KR 101738937B1
Authority
KR
South Korea
Prior art keywords
canine
virus
seq
influenza
influenza virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020147017285A
Other languages
English (en)
Korean (ko)
Other versions
KR20140091770A (ko
Inventor
패티 씨. 크로우포드
폴 제이. 깁스
에드워드 제이. 두보비
로벤 오. 도니스
자쿠라인 캣즈
알렉산더 아이. 클리모브
낸시 제이. 콕스
윌리암 엘. 캐스틀맨
Original Assignee
더 거버먼트 오브 더 유나이티드 스테이츠 오브 아메리카, 애즈 레프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비시즈, 센터스 포 디지즈 컨트롤 앤드 프리벤션
유니버시티 오브 플로리다 리서치 파운데이션, 인크.
코넬 리서치 화운데이션,인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 더 거버먼트 오브 더 유나이티드 스테이츠 오브 아메리카, 애즈 레프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비시즈, 센터스 포 디지즈 컨트롤 앤드 프리벤션, 유니버시티 오브 플로리다 리서치 파운데이션, 인크., 코넬 리서치 화운데이션,인크. filed Critical 더 거버먼트 오브 더 유나이티드 스테이츠 오브 아메리카, 애즈 레프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비시즈, 센터스 포 디지즈 컨트롤 앤드 프리벤션
Publication of KR20140091770A publication Critical patent/KR20140091770A/ko
Application granted granted Critical
Publication of KR101738937B1 publication Critical patent/KR101738937B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/145Orthomyxoviridae, e.g. influenza virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08RNA viruses
    • C07K14/11Orthomyxoviridae, e.g. influenza virus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16121Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
KR1020147017285A 2005-04-21 2006-04-21 개과 동물의 호흡기 질병 조절을 위한 물질 및 방법들 Active KR101738937B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US67344305P 2005-04-21 2005-04-21
US60/673,443 2005-04-21
PCT/US2006/015090 WO2006116082A1 (en) 2005-04-21 2006-04-21 Materials and methods for respiratory disease control in canines

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020077027141A Division KR101474011B1 (ko) 2005-04-21 2007-11-21 개과 동물의 호흡기 질병 조절을 위한 물질 및 방법들

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020157015702A Division KR101738940B1 (ko) 2005-04-21 2006-04-21 개과 동물의 호흡기 질병 조절을 위한 물질 및 방법들

Publications (2)

Publication Number Publication Date
KR20140091770A KR20140091770A (ko) 2014-07-22
KR101738937B1 true KR101738937B1 (ko) 2017-05-23

Family

ID=37215064

Family Applications (3)

Application Number Title Priority Date Filing Date
KR1020147017285A Active KR101738937B1 (ko) 2005-04-21 2006-04-21 개과 동물의 호흡기 질병 조절을 위한 물질 및 방법들
KR1020157015702A Active KR101738940B1 (ko) 2005-04-21 2006-04-21 개과 동물의 호흡기 질병 조절을 위한 물질 및 방법들
KR1020077027141A Expired - Fee Related KR101474011B1 (ko) 2005-04-21 2007-11-21 개과 동물의 호흡기 질병 조절을 위한 물질 및 방법들

Family Applications After (2)

Application Number Title Priority Date Filing Date
KR1020157015702A Active KR101738940B1 (ko) 2005-04-21 2006-04-21 개과 동물의 호흡기 질병 조절을 위한 물질 및 방법들
KR1020077027141A Expired - Fee Related KR101474011B1 (ko) 2005-04-21 2007-11-21 개과 동물의 호흡기 질병 조절을 위한 물질 및 방법들

Country Status (16)

Country Link
EP (3) EP1871885B8 (enExample)
JP (6) JP2008536526A (enExample)
KR (3) KR101738937B1 (enExample)
CN (3) CN101253267A (enExample)
AU (1) AU2006240038B2 (enExample)
BR (2) BR122018012345B1 (enExample)
CA (1) CA2606429A1 (enExample)
ES (1) ES2570758T3 (enExample)
IL (3) IL186710A (enExample)
MX (3) MX339202B (enExample)
NO (2) NO345667B1 (enExample)
NZ (2) NZ583564A (enExample)
RU (2) RU2449014C2 (enExample)
SG (2) SG10201910006WA (enExample)
WO (1) WO2006116082A1 (enExample)
ZA (1) ZA200708897B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7959929B2 (en) 2005-04-21 2011-06-14 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
CN101253267A (zh) * 2005-04-21 2008-08-27 佛罗里达大学研究基金公司 用于犬科动物中呼吸系统疾病控制的物质和方法
US11865172B2 (en) 2005-04-21 2024-01-09 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US8124335B2 (en) 2005-05-06 2012-02-28 Gen-Probe Incorporated Compositions and assays to detect influenza virus A and B nucleic acids
US7425336B2 (en) * 2005-08-25 2008-09-16 Mevial Limited Canine influenza vaccines
NZ566490A (en) * 2005-10-07 2011-06-30 Pfizer Prod Inc Live attenuated or killed H3N8 influenza vaccines and methods to treat canine influenza
US7468187B2 (en) 2005-10-18 2008-12-23 Iowa State University Research Foundation, Inc. Canine influenza virus and related compositions and methods of use
AU2013205112C1 (en) * 2005-10-19 2015-12-03 Cornell Research Foundation, Inc. Influenza viruses able to infect canids, uses thereof
AU2006304747B2 (en) * 2005-10-19 2013-10-03 Cornell Research Foundation, Inc. Influenza viruses able to infect canids, uses thereof
WO2007047728A2 (en) * 2005-10-20 2007-04-26 Wyeth Compositions and methods for the treatment of canine influenza virus disease
GB0613977D0 (en) 2006-02-07 2006-08-23 Peptcell Ltd Peptide sequences and compositions
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
WO2008070332A2 (en) * 2006-10-25 2008-06-12 Intervet International B.V. Feline influenza vaccine and method of use
CN101838708B (zh) * 2010-03-30 2012-07-18 华南农业大学 一种检测犬流感的方法
EP2953967B1 (en) * 2013-02-07 2019-05-01 Massachusetts Institute of Technology Human adaptation of h5 influenza
CN103881983B (zh) * 2014-03-07 2016-08-31 中国农业科学院哈尔滨兽医研究所 重组犬流感病毒毒株、其制备方法及由其制备得到的疫苗
WO2017004453A1 (en) * 2015-07-02 2017-01-05 Indevr, Inc. Universal priming mixture for amplification of influenza viral gene segments for diagnostic applications
EP3980445A1 (en) * 2019-06-07 2022-04-13 Intervet International B.V. Mdbk irf3/irf7 knock out mutant cell and its use for vaccine production
CN110592276A (zh) * 2019-07-08 2019-12-20 北京世纪元亨动物防疫技术有限公司 用于检测犬流感病毒的特异性引物及试剂盒
CN115074461B (zh) * 2021-03-11 2023-08-25 上海市农业科学院 犬流感病毒、犬冠状病毒和犬呼肠孤病毒的三重pcr检测方法
CN115725517B (zh) * 2022-09-01 2026-01-02 军事科学院军事医学研究院军事兽医研究所 一种h3n2犬流感重组病毒株及其应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001060849A2 (en) * 2000-02-16 2001-08-23 The University Of Pittsburgh-Of The Commonwealth System Of Higher Education Cold-adapted equine influenza viruses

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5034322A (en) 1983-01-17 1991-07-23 Monsanto Company Chimeric genes suitable for expression in plant cells
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
US5106739A (en) 1989-04-18 1992-04-21 Calgene, Inc. CaMv 355 enhanced mannopine synthase promoter and method for using same
US6309647B1 (en) * 1999-07-15 2001-10-30 Aventis Pasteur Poxvirus—canine dispemper virus (CDV) or measles virus recombinants and compositions and methods employing the recombinants
US5756102A (en) * 1990-11-20 1998-05-26 Virogenetics Corporation Poxvirus-canine distemper virus (CDV) recombinants and compositions and methods employing the recombinants
US5994056A (en) 1991-05-02 1999-11-30 Roche Molecular Systems, Inc. Homogeneous methods for nucleic acid amplification and detection
US5612487A (en) 1991-08-26 1997-03-18 Edible Vaccines, Inc. Anti-viral vaccines expressed in plants
US5484719A (en) 1991-08-26 1996-01-16 Edible Vaccines, Inc. Vaccines produced and administered through edible plants
UA48104C2 (uk) 1991-10-04 2002-08-15 Новартіс Аг Фрагмент днк, який містить послідовність,що кодує інсектицидний протеїн, оптимізовану для кукурудзи,фрагмент днк, який забезпечує направлену бажану для серцевини стебла експресію зв'язаного з нею структурного гена в рослині, фрагмент днк, який забезпечує специфічну для пилку експресію зв`язаного з нею структурного гена в рослині, рекомбінантна молекула днк, спосіб одержання оптимізованої для кукурудзи кодуючої послідовності інсектицидного протеїну, спосіб захисту рослин кукурудзи щонайменше від однієї комахи-шкідника
RU2193065C2 (ru) * 1994-03-14 2002-11-20 Мерк энд Ко. Инк. Конструкция днк (варианты), днк-вектор, иммуногенная композиция против вируса гриппа, способ индукции иммунного ответа, вакцина и способ вакцинации
JP3745370B2 (ja) * 1994-03-30 2006-02-15 ヴァイロジェネティクス コーポレイション イヌヘルペスウイルスgB、gCおよびgDの、核酸およびアミノ酸配列とその利用
GB9524395D0 (en) 1995-11-29 1996-01-31 Nickerson Biocem Ltd Promoters
US6252139B1 (en) 1996-07-18 2001-06-26 The Salk Institute For Biological Studies Method of increasing growth and yield in plants
US6063385A (en) 1997-11-07 2000-05-16 Wisconsin Alumni Research Foundation DNA vaccine for parvovirus
US6472375B1 (en) 1998-04-16 2002-10-29 John Wayne Cancer Institute DNA vaccine and methods for its use
US6177082B1 (en) * 1998-08-13 2001-01-23 The University Of Pittsburgh-Of The Commonwealth System Of Higher Education Cold-adapted equine influenza viruses
US6579528B1 (en) * 1998-08-13 2003-06-17 The University Of Pittsburgh - Of The Commonwealth System Of Higher Education Cold-adapted equine influenza viruses
EP1133556B1 (en) 1998-11-24 2006-02-08 Pioneer Hi-Bred International, Inc. Root-preferred promoters and their use
JP2000230931A (ja) * 1998-12-07 2000-08-22 Katakura Industries Co Ltd 家畜インフルエンザウイルスに対する抗体の検出方法およびこれに用いるキット
DE19960843A1 (de) 1999-12-16 2001-06-28 Florian Grundler Wurzelspezifischer Promotor
HU229101B1 (en) * 2000-04-28 2013-07-29 St Jude Childrens Res Hospital Dna transfection system for the generation of infectious influenza virus
BR0111819A (pt) * 2000-06-23 2004-01-06 American Cyanamid Co Moléculas de ácido nucléico isoladas, e, seq ência de aminoácido isolada
US6455760B1 (en) 2000-11-16 2002-09-24 The Salk Institute Of Biological Studies Expression of flavin-containing monoxygenases in plants
US20040067506A1 (en) 2000-12-04 2004-04-08 Ben Scheres Novel root specific promoter driving the expression of a novel lrr receptor-like kinase
EP1494708A1 (en) * 2002-04-12 2005-01-12 Capua, Ilaria Purified subfragment codifying for neuroaminidase, recombinant neuroaminidase and its use in zooprophylaxis
US7285656B2 (en) 2002-04-26 2007-10-23 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Natural Resources Canada, Canadian Forest Service Root-specific conifer gene promoter and its use
WO2004029213A2 (en) * 2002-09-28 2004-04-08 Massachusetts Institute Of Technology Compositions and methods for delivery of short interfering rna and short hairpin rna
WO2004057021A2 (en) * 2002-12-19 2004-07-08 UNIVERSITé LAVAL Molecular methods and compositions for detecting and quantifying respiratory viruses
US20040123349A1 (en) 2002-12-20 2004-06-24 Qi Xie SINAT5, an Arabidopsis thaliana gene promotes ubiquitin related degradation
CA2523676A1 (en) * 2003-05-15 2005-02-17 The Board Of Regents For Oklahoma State University Dna vaccine expressing ha1 of equine-2 influenza virus
CN1458168A (zh) * 2003-06-02 2003-11-26 中国农业科学院哈尔滨兽医研究所 重组猪流感病毒np抗原、其制备方法及在诊断中的应用
US8592197B2 (en) 2003-07-11 2013-11-26 Novavax, Inc. Functional influenza virus-like particles (VLPs)
CN101253267A (zh) * 2005-04-21 2008-08-27 佛罗里达大学研究基金公司 用于犬科动物中呼吸系统疾病控制的物质和方法
NZ566490A (en) * 2005-10-07 2011-06-30 Pfizer Prod Inc Live attenuated or killed H3N8 influenza vaccines and methods to treat canine influenza
US7468187B2 (en) * 2005-10-18 2008-12-23 Iowa State University Research Foundation, Inc. Canine influenza virus and related compositions and methods of use
AU2006304747B2 (en) * 2005-10-19 2013-10-03 Cornell Research Foundation, Inc. Influenza viruses able to infect canids, uses thereof
WO2007047728A2 (en) * 2005-10-20 2007-04-26 Wyeth Compositions and methods for the treatment of canine influenza virus disease
US7682619B2 (en) * 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001060849A2 (en) * 2000-02-16 2001-08-23 The University Of Pittsburgh-Of The Commonwealth System Of Higher Education Cold-adapted equine influenza viruses

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
The detectives, CORNELL VETERINARY MEDICINE NEWSLETTER, 2014.12.31.*

Also Published As

Publication number Publication date
NZ562661A (en) 2010-04-30
ES2570758T3 (es) 2016-05-20
KR101738940B1 (ko) 2017-06-08
JP2020031658A (ja) 2020-03-05
MX2018010571A (es) 2022-01-25
AU2006240038B2 (en) 2012-07-05
RU2007143041A (ru) 2009-05-27
SG10201406043TA (en) 2014-11-27
EP2495326B1 (en) 2019-11-20
JP6663416B2 (ja) 2020-03-11
HK1111729A1 (zh) 2008-08-15
EP2489739A3 (en) 2013-08-28
JP2018050636A (ja) 2018-04-05
BR122018012345B1 (pt) 2021-10-26
NZ583564A (en) 2011-09-30
AU2006240038A1 (en) 2006-11-02
NO20180601A1 (no) 2008-01-21
EP2495326A3 (en) 2013-08-28
RU2020100038A (ru) 2021-07-09
IL208707B (en) 2020-01-30
MX358750B (es) 2018-08-31
KR101474011B1 (ko) 2014-12-23
EP1871885A4 (en) 2009-09-16
IL208707A0 (en) 2010-12-30
JP2008536526A (ja) 2008-09-11
KR20080039836A (ko) 2008-05-07
CN103451158B (zh) 2018-11-23
IL249236B (en) 2021-07-29
RU2011153597A (ru) 2013-07-10
CN107099512A (zh) 2017-08-29
ZA200708897B (en) 2009-01-28
EP2489739A2 (en) 2012-08-22
BRPI0610503A2 (pt) 2010-06-29
EP2489739B1 (en) 2019-11-20
BRPI0610503B1 (pt) 2022-05-31
KR20150082628A (ko) 2015-07-15
EP1871885A1 (en) 2008-01-02
JP2013031440A (ja) 2013-02-14
JP6042131B2 (ja) 2016-12-14
KR20140091770A (ko) 2014-07-22
EP1871885B1 (en) 2016-02-17
JP6301855B2 (ja) 2018-03-28
JP2015144604A (ja) 2015-08-13
NO345667B1 (no) 2021-06-07
WO2006116082A1 (en) 2006-11-02
RU2711791C2 (ru) 2020-01-22
EP2495326A2 (en) 2012-09-05
MX339202B (es) 2016-05-13
SG10201910006WA (en) 2019-11-28
JP2024043541A (ja) 2024-03-29
CA2606429A1 (en) 2006-11-02
IL186710A (en) 2017-09-28
NO342494B1 (no) 2018-06-04
IL249236A0 (en) 2017-01-31
EP1871885B8 (en) 2017-08-02
IL186710A0 (en) 2008-02-09
CN103451158A (zh) 2013-12-18
CN101253267A (zh) 2008-08-27
RU2449014C2 (ru) 2012-04-27
NO20075961L (no) 2008-01-21

Similar Documents

Publication Publication Date Title
KR101474011B1 (ko) 개과 동물의 호흡기 질병 조절을 위한 물질 및 방법들
US10258686B2 (en) Materials and methods for respiratory disease control in canines
KR101548436B1 (ko) 개과 동물의 호흡기 질병 조절을 위한 물질들 및 방법들
RU2811752C2 (ru) Материалы и методы, используемые для лечения респираторных заболеваний у собак
US11865172B2 (en) Materials and methods for respiratory disease control in canines
AU2020233708B2 (en) Materials and methods for respiratory disease control in canines
HK1111729B (en) Materials and methods for respiratory disease control in canines
HK1174061A (en) Materials and methods for respiratory disease control in canines
HK1174061B (en) Materials and methods for respiratory disease control in canines
HK1173189B (en) Materials and methods for respiratory disease control in canines
HK1173189A (en) Materials and methods for respiratory disease control in canines
HK1118563B (en) Influenza viruses able to infect canids, uses thereof
HK1167660B (en) Materials for respiratory disease control in canines

Legal Events

Date Code Title Description
A107 Divisional application of patent
A201 Request for examination
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20140623

Application number text: 1020077027141

Filing date: 20071121

PA0201 Request for examination
PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20140801

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20150312

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20140801

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

A107 Divisional application of patent
AMND Amendment
J201 Request for trial against refusal decision
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20150612

Application number text: 1020077027141

Filing date: 20071121

PJ0201 Trial against decision of rejection

Patent event date: 20150612

Comment text: Request for Trial against Decision on Refusal

Patent event code: PJ02012R01D

Patent event date: 20150312

Comment text: Decision to Refuse Application

Patent event code: PJ02011S01I

Appeal kind category: Appeal against decision to decline refusal

Appeal identifier: 2015101003336

Request date: 20150612

PB0901 Examination by re-examination before a trial

Comment text: Amendment to Specification, etc.

Patent event date: 20150612

Patent event code: PB09011R02I

Comment text: Request for Trial against Decision on Refusal

Patent event date: 20150612

Patent event code: PB09011R01I

Comment text: Amendment to Specification, etc.

Patent event date: 20150202

Patent event code: PB09011R02I

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20150805

Patent event code: PE09021S01D

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20160425

Patent event code: PE09021S01D

B701 Decision to grant
PB0701 Decision of registration after re-examination before a trial

Patent event date: 20161228

Comment text: Decision to Grant Registration

Patent event code: PB07012S01D

Patent event date: 20150714

Comment text: Transfer of Trial File for Re-examination before a Trial

Patent event code: PB07011S01I

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20170517

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20170517

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20200507

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20210506

Start annual number: 5

End annual number: 5